2006
DOI: 10.1002/ana.21040
|View full text |Cite
|
Sign up to set email alerts
|

Measuring cognitive outcome after subarachnoid hemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Surviving patients are at risk for potentially severe complications, including vasospasm, cognitive dysfunction and global brain atrophy [ 1 ]. Cognitive dysfunction afflicts up to half of survivors, manifests as deficits in memory, executive function and language [ 2 , 3 , 4 , 5 ], and is responsible for the fact that only a third of previously employed SAH survivors return to work [ 6 ]. Cognitive dysfunction may be linked to global brain atrophy, which is very common in SAH, is strongly associated with poor outcome [ 7 , 8 ], and correlates with the severity of the systemic inflammatory response [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Surviving patients are at risk for potentially severe complications, including vasospasm, cognitive dysfunction and global brain atrophy [ 1 ]. Cognitive dysfunction afflicts up to half of survivors, manifests as deficits in memory, executive function and language [ 2 , 3 , 4 , 5 ], and is responsible for the fact that only a third of previously employed SAH survivors return to work [ 6 ]. Cognitive dysfunction may be linked to global brain atrophy, which is very common in SAH, is strongly associated with poor outcome [ 7 , 8 ], and correlates with the severity of the systemic inflammatory response [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Mortality remains near 50%; 1 while relatively few SAH survivors have significant focal neurologic deficits of the sort that are common after ischemic stroke, long-term cognitive dysfunction is seen in 50% to 60%, allowing only 33% to return to their previous level of employment despite good neurologic outcome. 2 The long-term cognitive deficits after SAH cross numerous cognitive domains, including memory, executive function, and language (for review, see Al-Khindi, 3 ). Of the memory deficits, most 46 but not all 7 have documented visuospatial memory as being particularly affected.…”
Section: Introductionmentioning
confidence: 99%
“…Even in patients who initially show good clinical grade, poor outcome affects as much as about 30% of cases (Germanò et al, 1997(Germanò et al, , 1998aHaley, 2006;Molyneux et al, 2005). Although several pharmacological and treatment strategies have shown positive effects in preclinical SAH models, there have been notable difficulties in their clinical translation, with a large number of late phase II and III trials failing to confirm benefits in human subjects.…”
Section: Merlo Et Almentioning
confidence: 97%